Fundraising FoxIsrael Biotech Fund
Venture capitalRehovot · Seed–Series A · 4 people tracked
Also known as I.B.F. MANAGEMENT LTD.
Find your way into Israel Biotech Fund
Each arrow is one introduction. Sign up to fill in the first one.
Ask Melissa Fensterstock to introduce you to Sarit Steinberg
You →Melissa · together at IMMUNE Pharmaceuticals Ltd. →Sarit
Ask Jamie Chen to introduce you to David Sidransky
You →Jamie · together at Orgenesis →David
Ask Sam Okafor to introduce you to Ido Zairi
You →Sam · together at Israel Biotech Fund →Ido
- Yuval Cabilly43 people can intro you
Sign up to find every way you can get introduced to Israel Biotech Fund
- Your email: who you already know at Israel Biotech Fund, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Israel Biotech Fund team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Israel Biotech Fund invests in biotechnology and pharmaceutical companies based in or connected to Israel, operating across the development and growth stages. The fund focuses on building Israeli biotech enterprises with the objective of delivering capital appreciation to investors.
Source: firm website, verified Sep 29, 2026.
Team · 4 people
from public directoriesFounder mafia
2 people who came through Israel Biotech Fund went on to found or lead other companies.
What they invest in
from 17 of 19 portfolio companiesBiotech ×17Healthtech ×9Medical Devices ×7AI & Machine Learning ×5Deep Tech ×4Digital Health ×2Advanced Manufacturing ×1Longevity ×1
HQs:Israel×5United States×5
Investments · 19 tracked
founders shown can be your intro pathBy year:2023 · 12021 · 12020 · 12017 · 22015 · 38 dated
Champions Oncology offers a KRAS-focused preclinical platform built on patient-derived xenograft (PDX) models screened with the pan-RAS(ON) inhibitor daraxonrasib, combining in vivo pharmacology with multi-omic characterization to study drug response and resistance.
AI & Machine LearningBiotechHealthtechHackensack, US
Ronnie Morris(Executive Officer, Director)inRonnie Morris, M.D.(Executive Officer, Director)inJames McGorry(Executive Officer)David Miller(Chief Financial Officer)inJoel Ackerman(Executive Officer, Director)inRob Brainin(Chief Executive Officer)in
Board seatDavid Sidransky· per SEC Form D · $14M raise · filed Mar 2015
Co-investorsBattery VenturesNew Enterprise Associates (NEA)
Galmed is a pharmaceutical company developing metabolic and inflammatory therapeutic drugs through discovery and clinical trial phases.
BiotechTel Aviv
Allen Baharaff(Executive Officer, Director)Tali Gorfine(Executive Officer)Yohai Stenzler(Executive Officer)inLiat Hayardeny(Executive Officer)in
BoardChaim Hurvitz(Director)
Board seatDavid Sidransky· per SEC Form D · $350K raise · filed Aug 2017
MediWound is a biotechnology company developing enzymatic treatments that selectively remove eschar tissue while preserving healthy tissue for burns and chronic wounds.
BiotechHealthtechMedical DevicesYavne
Boaz Gur-Lavie(Chief Financial Officer)inSharon Malka(Director)inEty Klinger(Executive Officer, Director)inTzvi Palash(Executive Officer)Assaf Segal(Director)Sharon Kochan(Director)
Co-investorsClal Biotechnology IndustriesDeep InsightGandyr InvestmentsNew Era Capital PartnersPoint72 Ventures
AION Labs is a venture studio founded by pharmaceutical companies (AstraZeneca, Pfizer, Merck, Teva) alongside AWS and venture capital partners to build and scale companies applying AI and emerging technologies to drug discovery and development.
AI & Machine LearningBiotechDeep Tech
Dr. Yuval Cabily(Co-Founder & Managing Partner)Ido Zairi(Co-founder & Managing Partner)in
Co-investorsAmiti Ventures
Anser Bio is a biotech company focused on cancer research and drug development, working on areas such as exosome-based therapeutics, protein purification, and cell technologies.
BiotechDeep TechHealthtechMedical Devices
Lana Volokh(Co-founder)Alex Tendler(Co-founder)Yevgeny Tendler(CSO)
Co-investorsPeregrine Ventures
Vensica is a clinical-stage medical company developing ViXe, a needle-free treatment for overactive bladder that combines the neurotoxin Xeomin with Vibe, an ultrasound-based drug delivery device that microinjects medication into the bladder wall.
BiotechHealthtechMedical Devices
Avner Geva(CEO, Co-founder)inAvi Eftel(CTO, Co-founder)inRoger R. Dmochowski(CMO)Ken Berlin(Executive Chairman)in
Co-investorsTrendlines Group
Orgenesis provides decentralized manufacturing infrastructure for cell and gene therapies, enabling on-site processing of CGTs in regional centers through its POCare™ platform and OMPUL™ mobile processing units.
Advanced ManufacturingBiotechHealthtechMedical DevicesGermantown, US
Neil Reithinger(Executive Officer)inVered Caplan(Executive Officer, Director)inFerber Ferber(Executive Officer)Joseph Tenne(Executive Officer)inSarah Ferber(Executive Officer)
Board seatDavid Sidransky· per SEC Form D · $10M raise · filed Dec 2015
Co-investorsBoundary Holding
BiotechSan Diego, US
Jamie Sulley(Executive Officer, Director)Joanne Barsa(Executive Officer)
BoardFred Knoll(Director)David Sidrandky(Director)Patrick Ostronick(Director)
Board seatDavid Sidransky· per SEC Form D · $800K raise · filed Sep 2015
4C Biomed develops an immunological screening platform to identify drug targets for cancer immunotherapy development.
AI & Machine LearningBiotechDigital HealthHealthtechTel Aviv, IL
Anthony Angel(Chairman & Co-founder)Dr. Alan Barge(Chief Executive Officer & Co-founder)Dr. Eyal Greenberg(Chief Development Officer & Scientific Co-founder)Prof. Gal Markel(Chief Scientific Officer & Co-founder)Prof. Jacob Schachter(Chief Medical Officer & Co-founder)
Ayala Pharma is associated with pharmaceutical drug candidates including AL102, AL101, and BST-236; the page states that AL102 and AL101 were acquired by Immunome, Inc. in Q1 2024.
Biotech
Co-investorsaMoon
Biond Bio is a clinical-stage biotechnology company developing first-in-class antibody therapies for oncology and immune-mediated diseases, targeting immune evasion mechanisms and pathological pathways.
BiotechHealthtech
Co-investorsDeep InsightSBI JI Innovation Advisory Ltd.
Biosight was a pharmaceutical company that merged with Ayala Pharmaceuticals on October 19, 2023.
Biotech
Co-investorsSBI JI Innovation Advisory Ltd.Trendlines Group
Gamida Cell develops cell therapy treatments designed to expand and enhance cells for therapeutic applications.
BiotechHealthtechLongevityMedical Devices
Co-investorsHighbridgeShavit Capital
Nectin Therapeutics develops novel monoclonal antibodies and antibody-drug-conjugates to treat difficult-to-treat cancers by targeting immune evasion mechanisms.
BiotechDeep TechMedical Devices
Co-investorsPeregrine VenturesCancer Focus
Ukko develops immuno-therapeutics for life-threatening food allergies using a computational protein design platform.
AI & Machine LearningBiotechDigital HealthMountain View, US
Anat Binur(Executive Officer, Director)inYanay Ofran(Director)inJudith Weiss Paltiel(PhD, VP Development)in
BoardScott Brady(Director)Samir Kaul(Director)in
Co-investorsKhosla VenturesSanara CapitalWestern Technology InvestmentFall Line CapitalLeaps by BayerPeakBridge VC
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AdvaxisExoprotherPharma2B
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 4
3 IPOs · 1 acquisitions · showing 3Champions OncologyNASDAQ: CSBRGalmed PharmaceuticalsNASDAQ: GLMDMediwoundNASDAQ: MDWD
Frequently asked questions
- How many investments has Israel Biotech Fund made?
- Israel Biotech Fund has 19 tracked investments, 4 of which have exited.
- What stage does Israel Biotech Fund invest at?
- Israel Biotech Fund invests at the Seed, Series A stages.
- What sectors does Israel Biotech Fund focus on?
- Israel Biotech Fund focuses on Biotech, Digital Health, Medical Devices.
- Where is Israel Biotech Fund located?
- Israel Biotech Fund is headquartered in Rehovot, IL.
- Does Israel Biotech Fund lead rounds?
- Israel Biotech Fund has led 3 of the 3 rounds where its role is on record.
- Who does Israel Biotech Fund co-invest with?
- Israel Biotech Fund most often shares deals with Deep Insight, Amiti Ventures, Khosla Ventures, among 12 tracked co-investors.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
Correlation Ventures is a venture capital firm that emphasizes a fast, data-driven investment process, using a large VC dataset and its network to support startups.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.